Auteur S. ROLLES
|
Documents disponibles écrits par cet auteur (12)
Ajouter le résultat à votre sélection Affiner la recherche
This report is the culmination of over a decade's thinking and experience of campaigning for drug policy reform. This process has been informed recently by the 'Options for Control' seminar series held in conjunction with the Mannheim Centre for[...]As jurisdictions enact reforms creating legal access to cannabis for purposes other than exclusively "medical and scientific," tensions surrounding the existing UN drug treaties and evolving law and practice in Member States continue to grow. Ho[...]C. WILKINS, Auteur ; A. RITTER, Auteur du commentaire ; L. VON DIEMEN, Auteur du commentaire ; S. ROLLES, Auteur du commentaire ; D. KUSHLICK, Auteur du commentaire ; A. L. BRETTEVILLE-JENSEN, Auteur du commentaire ; B. HUGHES, Auteur du commentaire ; P. GRIFFITHS, Auteur du commentaire | 2014
Dans Addiction (Vol.109, n°10, October 2014) Article : PériodiqueBackground: New Zealand has recently attempted to address the underlying drivers of the escalating new psychoactive substances (NPS) ('legal highs') problem by establishing the world's first pre-market approval regulatory regime for NPS. NPS pro[...]This groundbreaking report has been published by an independent panel of experts set up by the Liberal Democrats. This report sets out how the legal production and supply of cannabis could work in the UK. It was established in the autumn by Libe[...]A number of countries - including Switzerland, the UK, Germany, the Netherlands and Canada - prescribe heroin for use under medical supervision, as part of successful programmes to treat long-term users of illicit opioids. Heroin-assisted treat[...]T. BRIGAUD, Directeur de publication ; C. DEBAULIEU, Coordonnateur ; N. LUHMANN, Coordonnateur ; O. MAGUET, Coordonnateur ; C. ANDREO ; O. BERNARD ; P. BOLO ; J. BYRNE ; A. COPPEL ; M. DAVID ; J. P. LHOMME ; F. MENNERET ; P. O'HARE ; F. OLIVET ; E. O'MARA ; S. ROLLES ; N. SIMONNOT ; A. WODAK | 2013
LivreDepuis près de 20 ans, Médecins du Monde développe une approche de Réduction des Risques (RdR) auprès des usagers de drogues et des personnes se prostituant. Grâce au soutien de l'Agence Française de Développement (AFD), l'association édite aujo[...]This is the second edition of our guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world, who are witnessing the question change fr[...]This is the third edition of our guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world, who have witnessed the questions change fr[...]The 'war on drugs' has been a global disaster leading to violence, exploitation and record numbers of drug-related deaths. We all recognise the need to do things differently. In this book we show why the responsible regulation of stimulant drugs[...]S. ROLLES ; F. MEASHAM | 2011
Dans International Journal of Drug Policy (Vol.22, n°4, July 2011) Article : PériodiqueIn a 2010 Lancet paper Nutt et al. propose a model for evaluating and ranking drug harms, building on earlier work by incorporating multi criteria decision analysis. It is argued that problems arise in modelling drug harms using rankable single [...]Coalition canadienne des politiques sur les drogues (CCPD) ; Global Drug Policy Observatory ; International Centre on Human Rights and Drug Policy ; Mexico United Against Crime ; Réseau juridique canadien VIH/sida = Canadian HIV/AIDS Legal Network ; Transform Drug Policy Foundation ; TNI ; Washington Office on Latin America ; D. R. BEWLEY-TAYLOR ; M. JELSMA ; S. ROLLES ; J. WALSH | 2016
RapportFRANÇAIS : Alors que des législatures adoptent des réformes établissant l'accès légal au cannabis pour des fins autres qu'exclusivement « médicales et scientifiques », les tensions entourant les traités actuels des Nations Unies en matière de d[...]In April [2016], the world will come together at the UN to discuss the future of international drug policy. It will be the first time that far-reaching drug policy reforms are meaningfully discussed at such a high level. The current enforcement[...]